Skip to main content
Caplight Logo









Cypre Inc.

Cypre Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://cypre.com

Last Round

Seed Round

Dec 22, 2023

Total Funding Raised

$1.33M

Company Overview

Cypre Inc. operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in August 2018.

Cypre Inc. is a biotechnology company that develops a 3D tumor modeling platform designed to improve the process of cancer drug development and precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cypre Inc. Comparables

Compare Cypre Inc. with similar companies based on industry and business-model similarity.

Cypre Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carcinotech
88%
ScreenIn3D
86%
Xilis
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cypre Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundDec 22, 2023
SeedAug 10, 2018
Convertible DebtJan 18, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Cypre Inc. Investors

Notable investors and investment history

Cypre Inc. investors
InvestorRounds
Hemi VenturesSeed
Kluz VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 49% MoM.

  • May 12, 2026

    Monthly visitors grew 1891% MoM, from 79 to 1.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Cypre Inc. Filings

Explore SEC and related filing metadata, where available.

Cypre Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cypre Inc.'s valuation, stock price, and market status.

Is Cypre Inc. a public or private company?

Cypre Inc. is a private company.

What is the current stock price of Cypre Inc.?

Cypre Inc. is a private company, so its shares have no public market price. Caplight tracks Cypre Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cypre Inc. worth (valuation)?

Valuation information for Cypre Inc. is not publicly available.

Can I buy Cypre Inc. stock?

Cypre Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cypre Inc.'s last funding round?

Cypre Inc.'s most recent funding round was Seed Round on December 22, 2023.

Who are the main investors in Cypre Inc.?

Key investors in Cypre Inc. include Hemi Ventures, Kluz Ventures.

Will Cypre Inc. IPO soon?

No public IPO plans have been announced for Cypre Inc..

How can I track Cypre Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Cypre Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range8
Year Founded2016
Last FundingDec 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?